Article
Over-expression of RRM2 Predicts Poor Prognosis in Hepatocellular Carcinoma: A Bioinformatics Analysis Based on TCGA Data
2022-03-11
Abstract excerpt
<h4>Background: </h4> Ribonucleotide reductase regulatory subunit M2 (RRM2) has been reported as an oncogene in some kinds of malignant tumors, such as lung adenocarcinoma, oral squamous cell carcinoma, glioblastoma, and breast cancer. However, there are few studies focus on the clinical significance of RRM2 in Hepatocellular Carcinoma. This work aimed to evaluate the significance of RRM2 in Hepatocellular carcino...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b6036a26-c1f1-5d0d-9385-d3b03856176d
- DOI
- 10.21203/rs.3.rs-1395238/v1
